Past Events - Research to Practice

May 29

Exciting CME Events in Chicago You Do Not Want to Miss

Cases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer

ExploreCases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer
May 29

Exciting CME Events in Chicago You Do Not Want to Miss

Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Advanced Gastroesophageal Cancers

ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Advanced Gastroesophageal Cancers
May 17

American Urological Association Annual Meeting

Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

ExploreSecond Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
May 17

American Urological Association Annual Meeting

Second Opinion: Optimal Management of Localized Renal Cell Carcinoma

ExploreSecond Opinion: Optimal Management of Localized Renal Cell Carcinoma
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Pancreatic Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Pancreatic Cancer
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Prostate Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Prostate Cancer
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Immunotherapeutic Approaches for Endometrial Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Immunotherapeutic Approaches for Endometrial Cancer
May 13

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Ovarian Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Ovarian Cancer
May 13

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates
May 6

Year in Review

Localized HR-Positive Breast Cancer

ExploreLocalized HR-Positive Breast Cancer
May 5

Year in Review

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

ExploreNon-Muscle-Invasive and Muscle-Invasive Bladder Cancer
Apr 30

What Clinicians Want to Know

Optimizing the Management of Metastatic Triple-Negative Breast Cancer

ExploreOptimizing the Management of Metastatic Triple-Negative Breast Cancer